1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,640 | 0,710 | 20:01 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:06 | 2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development | 223 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive treatment of varicose veins using High-Intensity... ► Artikel lesen | |
| 20.08. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 447 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 23.07. | Theraclion Initiates Its Commercial Momentum in the First Half of 2026 | 548 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 15.07. | Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL | 408 | Business Wire | Regulatory News:
Theraclion (Paris:ALTHE):
Listing venue: Euronext Growth Paris
PEA-PME eligible
ISIN Code: FR0010120402
Website: www.theraclion.com
Under the liquidity contract entrusted... ► Artikel lesen | |
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 09.07. | Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors | 456 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 02.07. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 394 | Business Wire | Article 223-16 Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 18.06. | Theraclion Announces the Evolution of Its Board of Directors | 912 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 08.06. | Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein With AMA CPT Editorial Panel Approval of a New Category III CPT Code | 454 | Business Wire | Regulatory News:
Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment... ► Artikel lesen | |
| 04.06. | Theraclion Announces First Clinical Deployment of Sonovein in Hainan, China | 532 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402 Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the... ► Artikel lesen | |
| 03.06. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 389 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 01.06. | Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented | 440 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse
Theraclion... ► Artikel lesen | |
| 11.05. | Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase | 491 | Business Wire | Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million
Regulatory News:
This press release and the information it contains... ► Artikel lesen | |
| 28.04. | Theraclion's non-invasive varicose treatment poised for FDA decision | 2 | The Armchair Trader | ||
| 23.04. | XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026 | 601 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026
Aktien
1 ID1000132806 PT Multi Bintang Indonesia... ► Artikel lesen | |
| 20.04. | Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription... | 837 | Business Wire | Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical... ► Artikel lesen | |
| 16.04. | Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook | 678 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.01. | Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up | 517 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 09.12.25 | Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements | 817 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.10.25 | Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results | 640 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 21.10.25 | Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China | 478 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 27,660 | -0,50 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen wegen... ► Artikel lesen | |
| MCKESSON | 774,40 | -0,64 % | ShinyHunters expose 6.4M in attack on medical supplier McKesson | ||
| INMODE | 12,850 | -0,43 % | InMode slips as unsolicited takeover offer from M.N. Business Strategy expires | ||
| HCA HEALTHCARE | 371,80 | +1,23 % | Dividendenbekanntmachungen (16.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ZAE000255915 8,5 ZAR 0,4531 EUR ACADEMY SPORTS AND OUTDOORS INC US00402L1070 0,15 USD 0,1299 EUR ALTAGAS LTD CA0213611001 0... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 525,00 | 0,00 % | Aktien KW 36 Iran, Zinsangst und Trump-"unsinn" bremsen - was wäre wenn? News. Rheinmetall. Vonovia. DEFAMA. Smartbroker. Sino. Trade Republic. Limes Schlosskliniken. Mutares. Symrise. Aroundtown. Enapter. Bilfinger. Nagarro. Haier Smart. Delivery Hero | Aktien - diese Woche im Niemandsland. Positiv am Ende der Woche steht wieder 26 am Anafng des DAX, aber Schwung nach oben fehlt. Impulse hätten Nvidia und die anderen Ki-Aktien mit teilweise beeindruckenden... ► Artikel lesen | |
| BEYOND AIR | 3,100 | -0,96 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 18,700 | -0,53 % | HEALTHCARE SERVICES GROUP INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| ADDUS HOMECARE | 98,50 | -1,50 % | Addus HomeCare auf der Jefferies Konferenz: Wachstum und Akquisitionspläne | ||
| INTERPACE BIOSCIENCES | - | - | Interpace Biosciences, Inc.: Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting | PARSIPPANY, NJ, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCID: IDXG) ("Interpace" or the "Company"), an emerging leader in enabling personalized medicine, today announced that... ► Artikel lesen | |
| MYOMO | 1,058 | -4,34 % | Myomo auf H.C. Wainwright Konferenz: Strategiewechsel zu Empfehlungen treibt Wachstum an | ||
| MODERN DENTAL | 0,845 | 0,00 % | Dividendenbekanntmachungen (09.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0,319 HKD 0,0349 EUR ANHUI CONCH CEMENT CO LTD ADR US0352431045 0,0958 USD 0,0824... ► Artikel lesen | |
| IVF HARTMANN | 131,00 | 0,00 % | IVF Hartmann erwirtschaftet im Halbjahr klar mehr Umsatz | Neuhausen am Rheinfall - Der Medizinalbedarf-Hersteller IVF Hartmann hat im ersten Halbjahr 2026 den Umsatz zweistellig gesteigert. Der Gewinn nahm im Vergleich dazu noch deutlicher zu. Die Prognose... ► Artikel lesen | |
| ICU MEDICAL | 135,00 | -0,74 % | ICU Medical auf Morgan Stanley Konferenz: Pumpenzyklus und Margen im Fokus | ||
| FRESENIUS | 46,140 | +1,65 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,360 | -1,31 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen |
Das Unternehmen THERACLION SA kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,622 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION SA finden Sie auf Wallstreet Online.